Clinical Trial Update: AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors [Phase 1, Phase 2]

View source ↗

Summary

The National Cancer Institute reports a Phase 1/Phase 2 trial of selumetinib (AZD6244 hydrogen sulfate) for children with neurofibromatosis type 1–associated ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• Selumetinib (selumetinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neurofibromatosis 1, Neurofibromatosis Type 1 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING